• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸盐对羟基磷灰石诱导草酸钙结晶以及磷酸钙晶体形成的影响。

The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.

作者信息

Berg C, Tiselius H G

机构信息

Department of Urology, University Hospital, Linköping, Sweden.

出版信息

Urol Res. 1989;17(3):167-72. doi: 10.1007/BF00256245.

DOI:10.1007/BF00256245
PMID:2546314
Abstract

The addition of different amounts of hydroxyapatite crystals (HAP) to a solution, metastably supersaturated with respect to calcium oxalate (CaOx) resulted in heterogenous crystallization at seed concentrations exceeding 0.2 mmol/l. The induction period varied between 1 and more than 8 h with the shortest period for a seed concentration of 2 mmol/l. Addition to the system of 1 and 2% of whole urine and citrate in concentrations corresponding to approximately 1% of that found in normal urine inhibited the crystallization for as long as 4 h. In a system supersaturated with respect to calcium phosphate (CaP) the total number of crystals was markedly reduced by citrate concentrations exceeding 0.5 mmol/l. The fractions of medium sized and large crystals were sharply reduced and small crystals predominated at higher citrate concentrations. This might indicate effects of citrate on both crystal growth and crystal aggregation. We conclude that increased citrate concentrations during treatment with alkali leads to a significant inhibition of CaOx growth on HAP as well as to a prevention of the formation of large CaP crystals from solutions supersaturated with respect to CaP.

摘要

向相对于草酸钙(CaOx)呈亚稳过饱和的溶液中添加不同量的羟基磷灰石晶体(HAP),在籽晶浓度超过0.2 mmol/L时会导致异质结晶。诱导期在1至8小时以上之间变化,籽晶浓度为2 mmol/L时诱导期最短。向体系中添加相当于正常尿液中约1%浓度的1%和2%的全尿及柠檬酸盐,可抑制结晶长达4小时。在相对于磷酸钙(CaP)过饱和的体系中,柠檬酸盐浓度超过0.5 mmol/L时,晶体总数会显著减少。中等大小和大晶体的比例急剧降低,在较高柠檬酸盐浓度下小晶体占主导。这可能表明柠檬酸盐对晶体生长和晶体聚集均有影响。我们得出结论,在用碱治疗期间柠檬酸盐浓度升高会显著抑制CaOx在HAP上的生长,并防止从相对于CaP过饱和的溶液中形成大的CaP晶体。

相似文献

1
The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.柠檬酸盐对羟基磷灰石诱导草酸钙结晶以及磷酸钙晶体形成的影响。
Urol Res. 1989;17(3):167-72. doi: 10.1007/BF00256245.
2
Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.镁、柠檬酸盐、柠檬酸镁和碱式柠檬酸镁作为尿液中草酸钙结晶的调节剂:对复发性特发性钙尿路结石患者的观察
Urol Res. 1999 Apr;27(2):117-26. doi: 10.1007/s002400050097.
3
Alkaline citrate in prevention of recurrent calcium oxalate stones.碱性柠檬酸盐预防草酸钙结石复发
Scand J Urol Nephrol Suppl. 1990;130:1-83.
4
Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules.具有与集合管中成分相对应的溶液在体积减少过程中的结晶:羟基磷灰石籽晶和尿大分子的影响。
Urol Res. 1999 Dec;27(6):417-25. doi: 10.1007/s002400050130.
5
Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?在高浓度尿液中,柠檬酸盐是草酸钙晶体生长的抑制剂吗?
Urol Res. 1996;24(2):67-71. doi: 10.1007/BF00431081.
6
Effects of citrate on the different phases of calcium oxalate crystallization.柠檬酸盐对草酸钙结晶不同阶段的影响。
Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90.
7
Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.提高尿枸橼酸盐可降低全尿中草酸钙和磷酸钙晶体的形成。
Urol Int. 1983;38(3):179-81. doi: 10.1159/000280885.
8
[Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].[CG-120对草酸钙晶体体外形成、生长及聚集的抑制作用]
Hinyokika Kiyo. 1988 Jun;34(6):1073-6.
9
The effect of pH on the risk of calcium oxalate crystallization in urine.pH对尿液中草酸钙结晶风险的影响。
Eur Urol. 1986;12(1):59-61. doi: 10.1159/000472578.
10
The effect of seed crystals of hydroxyapatite and brushite on the crystallization of calcium oxalate in undiluted human urine in vitro: implications for urinary stone pathogenesis.羟基磷灰石和透钙磷石籽晶对未稀释人尿中草酸钙结晶的体外影响:对尿路结石发病机制的启示
Mol Med. 2002 Apr;8(4):200-9.

引用本文的文献

1
Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.枸橼酸钾与柠檬酸对磷酸钙结石形成者尿路结石风险的影响。
J Urol. 2018 Dec;200(6):1278-1284. doi: 10.1016/j.juro.2018.07.039. Epub 2018 Jul 20.
2
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.枸橼酸钾对高钙尿症模型中磷酸钙结石的影响。
J Am Soc Nephrol. 2015 Dec;26(12):3001-8. doi: 10.1681/ASN.2014121223. Epub 2015 Apr 8.
3
Pathophysiology-based treatment of idiopathic calcium kidney stones.

本文引用的文献

1
Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples.评估一种用于测定稀释尿液样本中草酸钙晶体生长抑制的常规方法。
Clin Chem. 1981 Apr;27(4):565-8.
2
Epitaxial considerations in urinary stone formation. II. The oxalate-phosphate system.尿路结石形成中的外延因素。II. 草酸盐-磷酸盐系统。
Invest Urol. 1981 Mar;18(5):358-63.
3
Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.提高尿枸橼酸盐可降低全尿中草酸钙和磷酸钙晶体的形成。
基于病理生理学的特发性钙肾结石治疗。
Clin J Am Soc Nephrol. 2011 Aug;6(8):2083-92. doi: 10.2215/CJN.11321210.
4
A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.钙结石形成的一种假说:对过去几十年结石研究的解读。
Urol Res. 2011 Aug;39(4):231-43. doi: 10.1007/s00240-010-0349-3. Epub 2011 Jan 19.
5
Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.磷酸钙在草酸钙晶体形成过程中的作用研究。
Urol Res. 2009 Aug;37(4):181-92. doi: 10.1007/s00240-009-0191-7. Epub 2009 May 15.
6
An understanding of renal stone development in a mixed oxalate-phosphate system.对草酸-磷酸盐混合体系中肾结石形成的理解。
Langmuir. 2008 Jul 15;24(14):7058-60. doi: 10.1021/la8007987. Epub 2008 Jun 17.
7
Intratubular crystallization events.肾小管内结晶事件。
World J Urol. 1997;15(4):219-28. doi: 10.1007/BF01367659.
8
Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.远端小管中磷酸钙和草酸钙的过饱和度估计水平。
Urol Res. 1997;25(2):153-9. doi: 10.1007/BF01037933.
9
Citrate and urease-induced crystallization in synthetic and human urine.柠檬酸盐和脲酶诱导的合成尿液及人尿液中的结晶
Urol Res. 1993 Mar;21(2):109-15. doi: 10.1007/BF01788828.
10
Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?磷酸钙:复发性钙结石形成患者的一种重要晶相?
Urol Res. 1993 May;21(3):175-80. doi: 10.1007/BF00590033.
Urol Int. 1983;38(3):179-81. doi: 10.1159/000280885.
4
Composition of urinary calculi by x-ray diffraction. Collected data from various localities. II. Czechoslovakia.通过X射线衍射分析尿结石的成分。收集来自不同地区的数据。二、捷克斯洛伐克
Br J Urol. 1968 Aug;40(4):402-11. doi: 10.1111/j.1464-410x.1968.tb11822.x.
5
Epitaxy as a growth factor in urinary calculi and gallstones.外延生长作为尿路结石和胆结石形成的一个生长因素。
Nature. 1968 Jan 6;217(5123):56-8. doi: 10.1038/217056a0.
6
The growth of hydroxyapatite crystals.羟基磷灰石晶体的生长。
Arch Oral Biol. 1970 Aug;15(8):731-45. doi: 10.1016/0003-9969(70)90037-3.
7
Crystallographic studies on the formation of renal calculi.肾结石形成的晶体学研究。
Biochem J. 1971 Mar;122(1):6P-7P. doi: 10.1042/bj1220006p.
8
The effect of pH on the risk of calcium oxalate crystallization in urine.pH对尿液中草酸钙结晶风险的影响。
Eur Urol. 1986;12(1):59-61. doi: 10.1159/000472578.
9
Long-term treatment of calcium nephrolithiasis with potassium citrate.枸橼酸钾对钙结石症的长期治疗
J Urol. 1985 Jul;134(1):11-9. doi: 10.1016/s0022-5347(17)46962-x.
10
EQUIL2: a BASIC computer program for the calculation of urinary saturation.EQUIL2:一个用于计算尿液饱和度的BASIC计算机程序。
J Urol. 1985 Dec;134(6):1242-4. doi: 10.1016/s0022-5347(17)47703-2.